Efficacy and safety of Shenyankangfu tablets for primary glomerulonephritis: study protocol for a randomized controlled trial.
Kou, Jia; Wu, Jie; Yang, Hong-tao; He, Ya-ni; Fang, Jing-ai; Deng, Yue-yi; Xie, Yuan-sheng; Nie, Li-fang; Lin, Hong-li; Cai, Guang-yan; Chen, Xiang-mei.
; 15: 479, 2014 Dec 05.
Artigo em Inglês | MEDLINE | ID: mdl-25480673
The role of podocytes dysfunction in chronic glomerulonephritis progression.
[Multi-center randomized control study on the effects of syndrome differentiated traditional Chinese medicine therapy on CKD 1-2 with chronic nephritis proteinuria].
[Effect of Astragali and Angelica particle on proteinuria in Chinese patients with primary glomerulonephritis].
Efficacy and safety of Abelmoschus manihot for primary glomerular disease: a prospective, multicenter randomized controlled clinical trial.
Prolonged Duration of Renal Recovery Following ANCA-Associated Glomerulonephritis.
Immunosuppressive Treatment in C3 Glomerulopathy: Is it Really Effective?
Clinical manifestations and outcome of ANCA-related pauci-immune glomerulonephritis in patients with Sjögren's syndrome.
[The research on xiaochalhu decoction improving the inflammation of chronic glomerulonephritis patients and relieving the proteinuria].
Renal histological features of school-age children with asymptomatic haematuria and/or proteinuria: a multicenter study.
[Determining of cytokine levels in the urine in clinical practice.]